Founder of SIRPant Immunotherapeutics, Inc., Richard F. Fitzgerald is Chief Financial Officer for CleanTech Acquisition Corp. Mr. Fitzgerald is also on the board of Bucknell University Alumni Association and Member of The American Institute of Certified Public Accountants and Member of Pennsylvania Institute of Certified Public Accountants.

Mr. Fitzgerald previously was Chairman at Dillon Consulting Ltd., Chief Financial Officer & Vice President at Nucleonics, Inc., Chief Financial Officer & Head-Investor Relations of Techprecision Corp., Chief Financial Officer of 22nd Century Group, Inc., Chief Financial Officer of Immunome, Inc., Chief Financial Officer & Secretary for PAVmed, Inc., Chief Financial Officer & Treasurer of Sesen Bio, Inc., Chief Financial Officer at SIRPant Immunotherapeutics, Inc., Director-Corporate Development at Exelon Corp. and Director-Corporate Development at PECO Energy Co. (a subsidiary of Exelon Corp.), Senior Manager-Audit & Transaction Services at PricewaterhouseCoopers LLP and Co-Chairman of Biotechnology Innovation Organization.

He received an undergraduate degree from Bucknell University.